Related references
Note: Only part of the references are listed.Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing
Yiran Guo et al.
BMC MEDICAL GENETICS (2017)
Clinical features of olfactory reference syndrome: An internet-based study
Jennifer L. Greenberg et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2016)
Survey of variants of human flavin-containing monooxygenase 3 (FMO3) and their drug oxidation activities
Hiroshi Yamazaki et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Variants in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population
Makiko Shimizu et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Individuals Reporting Idiopathic Malodor Production: Demographics and Incidence of Trimethylaminuria
Paul M. Wise et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Olfactory reference syndrome: demographic and clinical features of imagined body odor
Katharine A. Phillips et al.
GENERAL HOSPITAL PSYCHIATRY (2011)
Olfactory reference syndrome treated by blonanserin augmentation
Yoshiteru Takekita et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2011)
Olfactory reference syndrome: a systematic review of the world literature
M. Begum et al.
PSYCHOLOGICAL MEDICINE (2011)
L-Carnitine treatment and fish odor syndrome: An unwaited adverse effect
F. Rocher et al.
REVUE NEUROLOGIQUE (2011)
Measurement of urinary trimethylamine and trimethylamime oxide by direct infusion electrospray quadrupole time-of-flight mass spectrometry
Orval A. Mamer et al.
ANALYTICAL BIOCHEMISTRY (2010)
OLFACTORY REFERENCE SYNDROME: ISSUES FOR DSM-V
Jamie D. Feusner et al.
DEPRESSION AND ANXIETY (2010)
A flow injection electrospray ionization tandem mass spectrometric method for the simultaneous measurement of trimethylamine and trimethylamine N-oxide in urine
David W. Johnson
JOURNAL OF MASS SPECTROMETRY (2008)
Flavin-containing monooxygenases: mutations, disease and drug response
Ian R. Phillips et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Functional characterization of genetic variants of human FMO3 associated with trimethylaminuria
Catherine K. Yeung et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency
Rikke K. J. Olsen et al.
BRAIN (2007)
Effect of genetic variants of the human flavin-containing monooxygenase 3 on N- and S-oxygenation activities
Makiko Shimizu et al.
DRUG METABOLISM AND DISPOSITION (2007)
Stop codon mutations in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population
Hiroshi Yamazaki et al.
MOLECULAR GENETICS AND METABOLISM (2007)
Rapid screening assay of trimethylaminuria in urine with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Wei-Yi Hsu et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2007)
Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children
RA Chalmers et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
Diagnosis of suspected trimethylaminuria by NMR spectroscopy
P Podadera et al.
CLINICA CHIMICA ACTA (2005)
Do olfactory reference syndrome and Jiko-shu-kyofu (a subtype of Taijin-kyofu) share a common entity?
K Suzuki et al.
ACTA PSYCHIATRICA SCANDINAVICA (2004)
Two new polymorphisms of the FMO3 gene in caucasian and African-American populations:: Comparative genetic and functional studies
V Lattard et al.
DRUG METABOLISM AND DISPOSITION (2003)
Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria
JR Cashman et al.
CURRENT DRUG METABOLISM (2003)
Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans
B Furnes et al.
DRUG METABOLISM AND DISPOSITION (2003)
Ethnic differences in allelic frequency of two flavin-containing monooxygenase 3 (FMO3) polymorphisms: linkage and effects on in vivo and in vitro FMO activities
CS Park et al.
PHARMACOGENETICS (2002)
In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene
DM Lambert et al.
MOLECULAR GENETICS AND METABOLISM (2001)
Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FMO3) gene in patients with fish-odour syndrome
CT Dolphin et al.
PHARMACOGENETICS (2000)
Share Paper
